L&K Biomed Ltd. (KOSDAQ:156100)

L&K Biomed Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4,803	3,835	5,047	7,395	16,108	4,910
Short-Term Investments	5,608	16,108	7,729	5,608	3,108	3,306
Cash & Short-Term Investments	10,411	19,943	12,776	13,003	19,216	8,216
Cash Growth	-48.35%	56.10%	-1.75%	-32.33%	133.88%	68.81%
Accounts Receivable	16,963	14,980	9,839	5,780	1,526	3,084
Other Receivables	682.27	290.26	1,066	223.05	635.92	203.53
Receivables	17,926	16,015	10,905	6,003	2,162	3,309
Inventory	30,363	24,551	19,089	16,366	13,856	19,358
Prepaid Expenses	718.56	525.95	656.55	444.63	688.1	310.2
Other Current Assets	1,033	2,532	990.85	330.62	2,042	851.06
Total Current Assets	60,452	63,566	44,417	36,147	37,964	32,044
Property, Plant & Equipment	9,800	10,005	9,012	8,514	9,271	7,890
Long-Term Investments	592.08	577.5	1,049	64.15	1,203	1,755
Goodwill	-	-	-	-	-	244.11
Other Intangible Assets	1,051	998.17	798.73	715.11	1,209	836.23
Long-Term Accounts Receivable	3,698	1,807	1,281	2,385	5,200	5,006
Long-Term Deferred Tax Assets	5,228	5,009	5,516	3,902	3,591	8,515
Long-Term Deferred Charges	-	-	-	106.09	223.63	427.86
Other Long-Term Assets	1,374	798.55	387.38	829.96	623.29	2,278
Total Assets	82,196	83,061	62,762	52,663	59,285	58,995
Accounts Payable	2,707	3,347	2,047	2,437	498.73	1,384
Accrued Expenses	836.35	851.44	685.87	589.86	606.95	791.83
Short-Term Debt	18,230	20,558	10,040	20,406	6,692	12,434
Current Portion of Long-Term Debt	800	800	100	2,800	-	3,128
Current Portion of Leases	730.43	669.07	828.69	750.57	636.63	572.79
Current Income Taxes Payable	1.89	7.29	0.35	54.09	0.89	3.59
Other Current Liabilities	9,204	12,841	9,062	10,943	4,177	1,350
Total Current Liabilities	32,509	39,074	22,763	37,981	12,613	19,664
Long-Term Debt	1,000	1,000	1,700	-	13,608	2,100
Long-Term Leases	1,453	369.63	845.16	1,244	1,518	1,751
Pension & Post-Retirement Benefits	3,210	3,057	2,232	1,574	1,330	1,263
Long-Term Deferred Tax Liabilities	1,269	1,569	1,361	1,047	-	-
Other Long-Term Liabilities	117.17	1,958	3,274	55.37	5,429	54.28
Total Liabilities	39,557	47,028	32,175	41,902	34,499	24,832
Common Stock	10,378	9,968	9,968	6,703	6,696	6,635
Additional Paid-In Capital	61,046	90,386	90,386	68,174	67,992	63,616
Retained Earnings	-25,274	-58,746	-67,849	-65,348	-51,884	-40,051
Treasury Stock	-0.09	-0.09	-0.09	-0.09	-0.09	-0.09
Comprehensive Income & Other	2,562	887.93	2,846	2,740	1,663	1,415
Total Common Equity	48,711	42,496	35,351	12,268	24,467	31,615
Minority Interest	-6,072	-6,463	-4,764	-1,507	319.82	2,548
Shareholders' Equity	42,639	36,033	30,587	10,762	24,787	34,163
Total Liabilities & Equity	82,196	83,061	62,762	52,663	59,285	58,995
Total Debt	22,213	23,397	13,513	25,201	22,456	19,986
Net Cash (Debt)	-11,801	-3,454	-737.76	-12,198	-3,240	-11,770
Net Cash Per Share	-548.67	-160.55	-45.50	-910.57	-242.05	-989.82
Filing Date Shares Outstanding	20.76	19.94	19.94	13.41	13.39	13.24
Total Common Shares Outstanding	20.76	19.94	19.94	13.41	13.39	13.27
Working Capital	27,944	24,492	21,654	-1,834	25,351	12,380
Book Value Per Share	2346.93	2131.56	1773.17	915.17	1826.89	2382.37
Tangible Book Value	47,661	41,498	34,553	11,553	23,258	30,534
Tangible Book Value Per Share	2296.30	2081.50	1733.11	861.82	1736.61	2300.96
Land	737.02	737.02	737.02	737.02	737.02	1,079
Buildings	2,502	2,502	2,502	2,502	2,502	3,682
Machinery	17,291	16,491	14,307	12,330	11,671	5,884
Construction In Progress	84	59	-	-	-	225.65

Source: S&P Global Market Intelligence. Standard template. Financial Sources.